肝脏超声造影对原发性肝癌微波消融术后血供状态评估的价值

肝脏 ›› 2022, Vol. 27 ›› Issue (6): 637-639.

肝脏超声造影对原发性肝癌微波消融术后血供状态评估的价值

周成香, 刘亚斌, 苏红, 蒋怡香, 林海燕

610500 成都医学院第一附属医院超声科(周成香,苏红,蒋怡香,林海燕),放射科(刘亚斌)

收稿日期:2021-08-12 出版日期:2022-06-30 发布日期:2022-08-04
通讯作者: 刘亚斌,Email:3657181@qq.com
基金资助:
四川省医学科研课题计划项目(Q18005)

The evaluation value of contrast-enhanced ultrasound on blood supply in patients with primary liver cancer after microwave ablation

ZHOU Cheng-xiang¹, LIU Ya-bin², SU Hong¹, JIANG Yi-xiang¹, LIN Hai-yan¹

1. Department of Ultrasound, the First Affiliated Hospital of Chengdu Medical College, Sichuan 610500, China;
2. Department of Radiology, the First Affiliated Hospital of Chengdu Medical College, Sichuan 610500, China

Received:2021-08-12 Online:2022-06-30 Published:2022-08-04
Contact: LIU Ya-bin,Email:3657181@qq.com

摘要/Abstract

摘要： 目的探讨肝脏超声造影(CEUS)对原发性肝癌(PLC)微波消融术后血供状态的评估价值。方法选取2017年6月至2021年3月成都医学院第一附属医院收治的行微波消融术的PLC患者66例,合计病灶72个。于患者术后1个月行X线数字减影血管造影(DSA)、增强X线计算机断层扫描(CT)及CEUS检查,统计不同检查方式中患者病灶残存血供情况,以DSA检查病灶残存血供结果作为金标准,采用一致性分析增强CT及CEUS对术后病灶残存血供的诊断价值。结果肝癌患者消融术后,DSA显示无残存血供病灶13个,残存血供病灶59个,增强CT显示无残存血供病灶18个,残存血供病灶54个,CEUS显示无残存血供病灶13个,残存血供病灶59个。经一致性分析,72个病灶中增强CT检查阳性54例,灵敏度为0.915,特异度为1.000,准确率为0.931,Kappa为0.796。经一致性分析,72个病灶中CEUS检查阳性59例,灵敏度为1.000,特异度为1.000,准确率为1.000,Kappa为1.000。结论 CEUS用于评估PLC患者微波消融术后病灶残存血供准确率较高,值得临床推广。

关键词: 超声造影, 原发性肝癌, 微波消融术, 血供

Abstract: Objective To investigate the evaluation value of contrast-enhanced ultrasound (CEUS) on blood supply in patients with primary liver cancer (PLC) after microwave ablation (MWA).Methods Sixty-six patients with PLC who underwent MWA in our hospital were selected, with a total of 72 lesions. Patients underwent digital subtraction angiography (DSA), enhanced X-ray computed tomography (CT) and CEUS at 1 month after operation. The blood supply of the lesions in the 3 groups was recorded, the angiographic result of DSA was regarded as the gold standard. Consistency analysis was used to evaluate the diagnostic value of enhanced CT and CEUS.Results There was blood supply in the lesion after MWA. The angiographic result of DSA showed that there was not blood supply in 13 lesions and there was blood supply in 59 lesions. Enhanced CT showed that there was not blood supply in 18 lesions and there was blood supply in 54 lesions. The angiographic result of CEUS showed that there was not blood supply in 13 lesions and there was blood supply in 59 lesions. According to the consistency analysis, 54 of 72 lesions were positive by enhanced CT, with a sensitivity of 0.915, a specificity of 1.000, an accuracy of 0.931 and a kappa of 0.796. By consistency analysis, 59 of 72 lesions were positive by CEUS, with a sensitivity of 1.000, a specificity of 1.000, an accuracy of 1.000 and a kappa of 1.000.Conclusion CEUS has a higher accuracy in evaluating blood supply of lesions in PLC patients after MWA, which is worthy of clinical promotion.

Key words: Ultrasound, Primary liver cancer, Microwave ablation, Blood supply

周成香, 刘亚斌, 苏红, 蒋怡香, 林海燕. 肝脏超声造影对原发性肝癌微波消融术后血供状态评估的价值[J]. 肝脏, 2022, 27(6): 637-639.

ZHOU Cheng-xiang, LIU Ya-bin, SU Hong, JIANG Yi-xiang, LIN Hai-yan. The evaluation value of contrast-enhanced ultrasound on blood supply in patients with primary liver cancer after microwave ablation[J]. Chinese Hepatolgy, 2022, 27(6): 637-639.

参考文献

[1] Ni JY, Fang ZT, Sun HL, et al. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.Eur Radiol, 2020,30(4):2377-2390.
[2] 王海军, 程瑞洪, 王朝晖, 等. 超声造影在肝动脉化疗栓塞术联合微波消融治疗肝癌效果评估中的应用.北华大学学报(自然科学版),2017,18(5):645-648.
[3] Jin T, Liu X, Dai C, et al. Beneficial impact of microwave ablation-assisted laparoscopic hepatectomy in cirrhotic hepatocellular carcinoma patients: a propensity score matching analysis. Int J Hyperthermia, 2019, 36(1):530-537.
[4] 强江丽, 孙成瑜, 雷凯荣. 超声超微细彩色血管成像技术用于原发性肝癌病灶血供的评价. 中国肿瘤临床与康复, 2019, 26(3):34-37.
[5] 肖东健, 王勇, 岳鑫,等. DSA和CTA在中晚期肝癌血供及灌注研究中的应用. 中国CT和MRI杂志, 2020, 18(3):5-7+14.
[6] 温瑜鹏, 刘彦君. 超声造影对原发性肝癌术后复发转移的诊断价值. 肝脏, 2018, 23(4):321-322.
[7] 程建美,李明奎,彭婵娟,等. 超声造影在诊断甲状腺乳头状癌被膜侵犯中的应用价值.中华医学超声杂志(电子版),2020,17(8):737-741.
[8] 高美莹, 葛辉玉, 苗立英,等. 超声造影鉴别诊断胃间质瘤与BormannⅡ型胃癌. 中国医学影像技术, 2017, 33(2):227-231.
[9] 中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准.中华肝脏病杂志,2001,9(6):324-324.
[10] 刘晓琳, 徐锋, 王超,等. 微波消融联合腔镜技术在肝癌治疗中的研究进展. 中国普外基础与临床杂志, 2017, 24(5):649-653.
[11] 程晓雪, 周臻涛, 罗可. 超声引导微波消融术个体化方案在危险部位肝癌治疗中的应用. 中国医师杂志, 2019, 21(8):27-30.
[12] 李蓬, 吴海燕, 龚心德,等. 超声造影技术对原发性肝癌介入治疗效果的评估价值. 中国数字医学, 2018, 13(10):66-68.
[13] 王曦, 李东, 何芬,等. 超声造影与增强CT评估TACE治疗原发性肝癌疗效的价值对比. 河北医学, 2018, 24(7):61-64.
[14] 樊建朝, 赵香田. 核磁共振,增强CT及超声造影对肝癌介入治疗疗效评估的对比研究. 中西医结合肝病杂志, 2019, 29(5):83-85.
[15] 王立,李敏,黄冬花,,等.超声造影与增强CT检查诊断原发性肝癌的价值比较研究.实用肝脏病杂志,2017,20(5):627-628.
[16] 秦海英, 何光彬, 周婉,等. 超声造影实时动态观察特殊部位肝癌微波消融联合聚桂醇治疗的应用价值. 临床和实验医学杂志, 2019, 18(22):102-104.